National Contract Value Review is now in place for all research phases

Date: 25 November 2024

The National Contract Value Review (NCVR), in which the RDN plays a key operational role, is driving significant efficiencies in the research system. NCVR is a UK-wide process which has standardised pricing and contract terms for commercial research across the NHS. Initially implemented for phase 3 and 4 studies, in October 2024 it was extended to all trial phases and as such has become routine practice for commercial research in NHS organisations. General Practice continues to benefitfrom this approach through a voluntary sign up scheme. The number of days taken from initial service submission to first patient recruitment has fallen by 244 days since the 2019/20 financial year, when NCVR started. The timeline for contract signature has fallen by 146 days since NCVR went live nationally, in October 2022.

Click to go back to News Listing